BMS-663513

· Bristol-Myers Squibb

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for BMS-663513, covering 2009-09-04 to 2015-10-12. Get the full timeline:

Most recent: Clinical Trial Update: Study of BMS-663513 in Patients With Advanced Cancer [Phase 1, Phase 2]